Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-21

FDA Approved: ARFORMOTEROL TARTRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' supplemental application for arformoterol tartrate, a generic inhaled long-acting beta-agonist used to treat chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arformoterol tartrate (generic) (Arformoterol tartrate)

Snippet

SUPPL AP for ARFORMOTEROL TARTRATE (ARFORMOTEROL TARTRATE)